NYX-2925
- Generic Name
- NYX-2925
Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Aptinyx
- Target Recruit Count
- 310
- Registration Number
- NCT04147858
- Locations
- 🇺🇸
Aptinyx Clinical Site, Bellevue, Washington, United States
Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- Aptinyx
- Target Recruit Count
- 22
- Registration Number
- NCT03249103
- Locations
- 🇺🇸
Aptinyx Clinical Site, Cincinnati, Ohio, United States
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
- First Posted Date
- 2017-07-17
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- Aptinyx
- Target Recruit Count
- 301
- Registration Number
- NCT03219320
- Locations
- 🇺🇸
Aptinyx Clinical Site, Norfolk, Virginia, United States
Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers
- First Posted Date
- 2016-07-15
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Aptinyx
- Target Recruit Count
- 84
- Registration Number
- NCT02834741
- Locations
- 🇺🇸
Spaulding Clinical, West Bend, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath